Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 16, 2023

SELL
$96.41 - $126.61 $27,476 - $36,083
-285 Reduced 11.92%
2,106 $217,000
Q1 2023

May 04, 2023

BUY
$135.66 - $197.02 $2,713 - $3,940
20 Added 0.84%
2,391 $367,000
Q2 2022

Aug 03, 2022

BUY
$117.13 - $176.59 $35,139 - $52,977
300 Added 14.49%
2,371 $339,000
Q1 2022

May 16, 2022

SELL
$126.46 - $235.05 $31,615 - $58,762
-250 Reduced 10.77%
2,071 $357,000
Q4 2021

Feb 09, 2022

BUY
$225.82 - $368.51 $524,128 - $855,311
2,321 New
2,321 $589,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Wealth Effects LLC Portfolio

Follow Wealth Effects LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Effects LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Effects LLC with notifications on news.